Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ResMed
RMD
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$244.94
1.96
0.81%
At Close: -
$244.94
0
0.00%
After Hours: 4:39 PM EDT
15 minutes delayed
Get Report
Comment
ResMed (RMD) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for ResMed (NYSE:RMD) Stock
ResMed Stock (NYSE: RMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, September 18, 2024
Stocks Edge Lower As Fed Rate Decision Looms, Treasury Yields Rise As Odds Improve For Smaller Cut: What's Driving Markets Wednesday?
Piero Cingari
ResMed shares are trading lower after Wolfe R...
Benzinga Newsdesk
Needham Reiterates Hold on ResMed
Benzinga Newsdesk
Wolfe Research Downgrades ResMed to Underperf...
Benzinga Newsdesk
Wednesday, September 11, 2024
Reasons to Retain ResMed Stock in Your Portfolio for Now
Zacks
Monday, September 09, 2024
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
Benzinga Insights
ResMed shares are trading higher. The stock s...
Benzinga Newsdesk
Apple Announces New Sleep Apnea Features On A...
Benzinga Newsdesk
Wednesday, September 04, 2024
A Glimpse Into The Expert Outlook On ResMed Through 6 Analysts
Benzinga Insights
Needham Downgrades ResMed to Hold, Maintains ...
Benzinga Newsdesk
Tuesday, August 27, 2024
Smart Money Is Betting Big In RMD Options
Benzinga Insights
Friday, August 23, 2024
How Is The Market Feeling About ResMed?
Benzinga Insights
Tuesday, August 20, 2024
$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
Benzinga Insights
Monday, August 12, 2024
What's in Store for Cardinal Health in Q4 Earnings?
Zacks
Wednesday, August 07, 2024
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $9,500 Today
Benzinga Insights
Sunday, August 04, 2024
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Lekha Gupta
Friday, August 02, 2024
RBC Capital Maintains Sector Perform on ResMe...
Benzinga Newsdesk
ResMed's Q4 Earnings Surpass Estimates, Margins Expand
Zacks
Keybanc Maintains Overweight on ResMed, Raise...
Benzinga Newsdesk
ResMed Earnings Reflect Increased Demand For Sleep Devices, Performance Indicates Positive Dynamics, Opportunities
Vandana Singh
ResMed shares are trading lower. The company ...
Benzinga Newsdesk
Needham Reiterates Buy on ResMed, Maintains $...
Benzinga Newsdesk
Thursday, August 01, 2024
ResMed shares are trading lower. The company ...
Benzinga Newsdesk
ResMed Increases Quarterly Dividend From $0.4...
Benzinga Newsdesk
ResMed Q4 2024 Adj. EPS $2.08 Beats $2.07 Est...
Benzinga Newsdesk
Tuesday, July 30, 2024
ResMed's Options Frenzy: What You Need to Know
Benzinga Insights
Friday, July 26, 2024
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $16,000 Today
Benzinga Insights
Thursday, July 25, 2024
Behind the Scenes of ResMed's Latest Options Trends
Benzinga Insights
Tuesday, July 23, 2024
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
What 6 Analyst Ratings Have To Say About ResMed
Benzinga Insights
RBC Capital Maintains Sector Perform on ResMe...
Benzinga Newsdesk
Tuesday, July 09, 2024
Looking Into ResMed's Recent Short Interest
Benzinga Insights
Friday, July 05, 2024
Here's Why Staying Invested in Neogen Could be Beneficial
Zacks
Smart Money Is Betting Big In RMD Options
Benzinga Insights
Tuesday, July 02, 2024
$1000 Invested In This Stock 15 Years Ago Would Be Worth $9,600 Today
Benzinga Insights
Is It the Right Time to Hold Labcorp in Your Portfolio?
Zacks
Friday, June 28, 2024
This Is What Whales Are Betting On ResMed
Benzinga Insights
QIAGEN Backs New AAP Guidelines Supporting QFT-Plus Test
Zacks
Thursday, June 27, 2024
Charles River's RMS Growth Aids Amid FX Headwind
Zacks
Wednesday, June 26, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Tuesday, June 25, 2024
Illumina Rises on Conclusion of GRAIL Divestment
Zacks
Beyond The Numbers: 6 Analysts Discuss ResMed Stock
Benzinga Insights
Oppenheimer Downgrades ResMed to Perform
Benzinga Newsdesk
Monday, June 24, 2024
Abbott's EPD Expansion Continues Despite FX Headwind
Zacks
Why ResMed Shares Are Trading Lower Monday
Dylan Berman
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Semiconductor, Nvidia Woes Deepen; Nasdaq 100 Slips, Dow Rallies; Bitcoin Sinks To $60,400: What's Driving Markets Monday?
Piero Cingari
Citigroup Downgrades ResMed to Neutral
Benzinga Newsdesk
ResMed shares are trading lower following sle...
Benzinga Newsdesk
Nasdaq Futures Slip As Nvidia Sell-Off Continues, S&P 500 Futures Hold Up: Analyst Says 'Valuations Will Go Parabolic And It Will Be A Perfect Time To Sell'
Shanthi Rexaline
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch